July 13, 2025 - 03:52

In a remarkable achievement, SciChart has been awarded the title of Healthcare Tech of the Year at the 2025 National Technology Awards. This accolade highlights the company's innovative contributions to the healthcare sector, particularly in enhancing real-time clinical decision-making through advanced medical data visualization techniques.
The award recognizes SciChart's commitment to providing high-speed, interactive charting solutions that empower healthcare professionals to make informed decisions swiftly. By transforming complex medical data into clear and actionable visual insights, SciChart is setting new standards for data analysis in clinical environments. This technology not only improves patient outcomes but also streamlines workflows within medical facilities.
Healthcare professionals across various disciplines are increasingly adopting SciChart's solutions, appreciating the ability to visualize large datasets in real time. This recognition at the National Technology Awards underscores the vital role of technology in modern healthcare and the importance of tools that support clinicians in delivering high-quality patient care.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...